Table 3.
Cohort patients: comorbidities, according to the outcomes
| Comorbities | SG n(%) | DG n(%) | p-value |
|---|---|---|---|
| Hypertension | 213 (58) | 24 (73) | 0.09 |
| Anemia | 100 (27) | 17 (52) | 0.004 |
| Diabetes mellitus | 76 (21) | 7 (21) | 0.93 |
| Dyslipidemia | 39 (11) | 8 (24) | 0.04 |
| Coronary disease | 21 (06) | 8 (24) | <0.001 |
| Cardiac failure | 25 (07) | 3 (09) | 0.47 |
| Hypothyroidism | 27 (07) | 0 (00) | 0.15 |
| COPDa | 24 (06) | 1 (03) | 0.70 |
| Stroke | 19 (05) | 3 (09) | 0.40 |
| Atrial fibrillation | 17 (05) | 4 (12) | 0.08 |
| Chronic kidney disease stage ≥3 | 11 (03) | 7 (21) | <0.001 |
| Depression | 13 (04) | 2 (06) | 0.35 |
| Body mass index <16 | 6 (02) | 5 (16) | <0.001 |
| Dementia | 6 (02) | 2 (06) | 0.13 |
| Heart valve disease | 1 (0.3) | 3 (09) | <0.001 |
SG - survivor group; DG - death group;
a
chronic obstructive pulmonary disease.